Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
After eight weeks of selling off, the hedge fund bought back US stocks, achieving the fastest speed since 2021.
The US stock market is currently experiencing active buying and market growth, but the market's high valuation is a concerning issue that may trigger future adjustments.
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
Capricor Reports Positive Long-term Data for DMD Drug Deramiocel
Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy
7 Children Given Bluebird's Skysona Developed Blood Cancer: Study